Getahun Molla Kassa, Aaron G. Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman, Emebet Dagne, Andargachew Mulu, Obsie Baissa, Ora Paltiel, John F. Dillon, Elias Ali Yesuf, Matthew Hickman, Josephine G. Walker, Clare E. French, DESTINE NIHR Global Health Research Group
{"title":"撒哈拉以南非洲普通人群中丙型肝炎病毒的危险因素——系统评价数据分析","authors":"Getahun Molla Kassa, Aaron G. Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman, Emebet Dagne, Andargachew Mulu, Obsie Baissa, Ora Paltiel, John F. Dillon, Elias Ali Yesuf, Matthew Hickman, Josephine G. Walker, Clare E. French, DESTINE NIHR Global Health Research Group","doi":"10.1111/jvh.70065","DOIUrl":null,"url":null,"abstract":"<p>Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.</p>","PeriodicalId":17762,"journal":{"name":"Journal of Viral Hepatitis","volume":"32 10","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jvh.70065","citationCount":"0","resultStr":"{\"title\":\"Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa—An Analysis of Systematic Review Data\",\"authors\":\"Getahun Molla Kassa, Aaron G. Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman, Emebet Dagne, Andargachew Mulu, Obsie Baissa, Ora Paltiel, John F. Dillon, Elias Ali Yesuf, Matthew Hickman, Josephine G. Walker, Clare E. French, DESTINE NIHR Global Health Research Group\",\"doi\":\"10.1111/jvh.70065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.</p>\",\"PeriodicalId\":17762,\"journal\":{\"name\":\"Journal of Viral Hepatitis\",\"volume\":\"32 10\",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jvh.70065\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Viral Hepatitis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jvh.70065\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Viral Hepatitis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jvh.70065","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
了解丙型肝炎病毒(HCV)的危险因素对靶向筛查和预防至关重要。我们系统地回顾了撒哈拉以南非洲(SSA)普通人群中与HCV血清患病率相关的危险因素。报告SSA中HCV危险因素的社区观察性研究的HCV血清患病率的综合系统评价。使用Joanna Briggs Institute工具评估研究质量。随机效应荟萃分析用于估计95%置信区间(CI)的优势比(OR)。我们确定了92项研究。21-64岁组(OR = 1.77, 95% CI 1.17-2.68)和65岁以上组(OR = 11.75, 95% CI 5.51-25.05)的HCV血清患病率高于≤20岁组;未受过正规教育(OR = 1.78, 95% CI 1.35-2.35)与中学或以上学历相比,已婚(OR = 1.91, 95% CI 1.45-2.51)或离婚(OR = 3.20, 95% CI 1.91 - 5.36)与从未结婚相比。丙肝病毒的家族史(OR = 1.52, 95% CI 1.17 - -1.96),被一个人感染了艾滋病毒(OR = 2.64, 95% CI 1.61 - -4.33)或HBsAg阳性(OR = 1.66, 95% CI 1.10 - -2.50)都积极与丙肝病毒seroprevalence增加有关,就像有输血史(OR = 1.81, 95% CI 1.33 - -2.45),住院(OR = 1.55, 95% CI 1.22 - -1.96),手术(OR = 1.28, 95% CI 1.01 - -1.62),划痕(OR = 1.29, 95% CI 1.01 - -1.64)和注射毒品(或= 7.04,95% ci 1.16-42.68)。针对老年人和暴露于卫生保健相关因素人群的HCV筛查试点规划可能导致有效发现HCV病例,并减少SSA国家普通人群中未来的HCV暴露。
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa—An Analysis of Systematic Review Data
Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.
期刊介绍:
The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis. It solicits these articles from epidemiologists, clinicians, pathologists, virologists and specialists in transfusion medicine working in the field, thereby bringing together in a single journal the important issues in this expanding speciality.
The Journal of Viral Hepatitis is a monthly journal, publishing reviews, original work (full papers) and short rapid communications in the area of viral hepatitis. It brings together in a single journal important issues in this rapidly expanding speciality including articles from:
virologists;
epidemiologists;
clinicians;
pathologists;
specialists in transfusion medicine.